Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | current revision | |
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
| 02-7-25 by conan.macdougal... [email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module. | ||
| 07-26-24 by Annie Kim | ||
| 07-26-24 by Annie Kim | ||
| 07-26-24 by Annie Kim | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | CrCl ≥ 50 mL/min | 30 - 49 mL/min | 10 - 29 mL/min | < 10 mL/min |
|---|---|---|---|---|
| Orolabial/genital HSV infection (initial episode) OR recurrent episode treatment in people with HIV | 1000 mg PO q12h | 1000 mg PO q12h | 1000 mg PO q24h | 500 mg PO q24h |
| Orolabial/genital HSV suppression OR recurrent episode treatment | 500 mg PO q12h | 500 mg PO q12h | 500 mg PO q24h | 500 mg PO q24h |
| Primary Varicella/Herpes Zoster Infection | 1000 mg PO q8h | 1000 mg PO q12h | 1000 mg PO q24h | 500 mg PO q24h |
| Immunocompromised Prophylaxis | 500 mg PO q12h | 500 mg PO q12h | 500 mg PO q24h | 500 mg PO q24h |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
|
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
|---|---|---|
| HSV Infection |
500 mg PO qPM |
Insufficient data; contact ID pharmacy for more information |
| VZV Infection | ||
| Immunocompromised Prophylaxis |